Related Experiment Video
Updated: May 5, 2026
13:10
Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
Published on: September 25, 2016
9.4K
Toward improved thrombolysis in ischemic stroke: targeting nonfibrin components.
1Laboratory for Thrombosis Research, Department of Cardiovascular Sciences, KU Leuven Campus Kulak, Kortrijk, Belgium.
Summary
Targeting nonfibrin components in ischemic stroke offers new hope for improved thrombolysis. Novel strategies aim to overcome resistance to current fibrinolytic therapies, enhancing treatment effectiveness.
Area of Science:
- Cardiovascular Sciences
- Neurology
- Pharmacology
Background:
- Recombinant tissue plasminogen activators are the standard for ischemic stroke reperfusion but have limitations.
- Ischemic stroke thrombi are complex, containing fibrin and other components that resist lysis.
- Fibrinolysis resistance necessitates exploring alternative therapeutic targets.
Purpose of the Study:
- To review emerging strategies targeting nonfibrin components in ischemic stroke.
- To discuss the clinical implications of these novel thrombolytic approaches.
- To summarize recent advancements presented at the 2025 International Society on Thrombosis and Haemostasis Congress.
Main Methods:
- Review of current evidence on ischemic stroke thrombus composition.
- Analysis of emerging thrombolytic strategies targeting nonfibrin elements.
- Synthesis of data presented at the 2025 International Society on Thrombosis and Haemostasis Congress.
Main Results:
- Ischemic stroke thrombi comprise fibrin, cellular, and extracellular components contributing to resistance.
- Targeting nonfibrin components shows potential to enhance thrombolysis.
- Novel strategies are being developed to improve reperfusion therapy outcomes.
Conclusions:
- Understanding thrombus composition is key to developing more effective ischemic stroke treatments.
- Targeting nonfibrin components represents a promising frontier in stroke reperfusion therapy.
- Continued research and clinical trials are essential to validate these new approaches.
Related Concept Videos
01:16Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K